Cutaneous allergy to human (recombinant DNA) insulin.
Gonzalo
M A
MA
Servicio de Alergología, Hospital Infanta Cristina, Badajoz, Spain.
De Argila
D
D
Revenga
F
F
García
J M
JM
Díaz
J
J
Morales
F
F
D000284:Administration, Oral; D000328:Adult; D001706:Biopsy; D003876:Dermatitis, Atopic / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy; D003922:Diabetes Mellitus, Type 1 / Q000188:drug therapy*; D005260:Female; D006634:Histamine H1 Antagonists / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D007073:Immunoglobulin E / Q000032:analysis / Q000276:immunology; D007328:Insulin / Q000276:immunology* / Q000627:therapeutic use*; D011994:Recombinant Proteins / Q000276:immunology* / Q000627:therapeutic use; D012867:Skin / Q000276:immunology / Q000473:pathology; D012882:Skin Tests
D006634:Histamine H1 Antagonists; D007328:Insulin; D011994:Recombinant Proteins; D007073:Immunoglobulin E